Medical Instruments & Supplies
Industry
|
Healthcare
Sector
|
Mr. Albert G. White III
CEO
|
NASDAQ (NGS)
Exchange
|
US2166484020
ISIN
|
US
Country
|
15,000
Employees
|
11 Aug 2023
Last Dividend
|
20 Feb 2024
Last Split
|
30 Dec 1983
IPO Date
|
The Cooper Companies, Inc., through its subsidiaries, specializes in the development, manufacturing, and marketing of contact lens products. The organization is structured into two main segments: CooperVision and CooperSurgical. CooperVision deals primarily with vision correction products, serving a wide range of needs from myopia to presbyopia and astigmatism, across various global markets including the Americas, Europe, the Middle East, Africa, and the Asia Pacific. On the other hand, CooperSurgical focuses on products and services catering to family and women’s health care, ranging from fertility solutions to contraception and cryostorage services for cord blood and tissue, reaching health care professionals and patients worldwide. Founded in 1958 and headquartered in San Ramon, California, The Cooper Companies remain a prominent entity in the healthcare sector, meeting diverse medical requirements through innovative solutions and extensive distribution networks.
CooperVision
CooperSurgical